Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature
Solid organ transplant recipients on long-term immunosuppressive medication are at increased risk of developing malignancy, and treatment of advanced cancers with angiogenesis inhibitors in this context has not been widely studied. We present a case of recurrent high-grade serous ovarian carcinoma t...
Main Authors: | Lawrence Kasherman, Jeffrey Doi, Katherine Karakasis, Jeffrey Schiff, Abhijat Kitchlu, Stephanie Lheureux, Amit M. Oza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/1/64 |
Similar Items
-
Angiogenesis Inhibitors in NSCLC
by: Anna Manzo, et al.
Published: (2017-09-01) -
Angiogenesis Inhibitors in Small Cell Lung Cancer
by: Agnese Montanino, et al.
Published: (2021-05-01) -
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer
by: S Pignata
Published: (2013-06-01) -
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
by: Soysal D., et al.
Published: (2014-12-01) -
Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia
by: Mikhail Yur'evich Shvetsov, et al.
Published: (2009-08-01)